NDC 84381-110 – Rapiblyk
Landiolol Hydrochloride 280 mg/1 · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC84381-110
Product details
- Brand name
- Rapiblyk
- Generic name
- Landiolol
- Labeler
- AOP Orphan Pharmaceuticals GmbH
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA217202
- Marketed since
- August 7, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- beta-Adrenergic Blocker
Active ingredients
- Landiolol Hydrochloride 280 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 84381-110-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (84381-110-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE | Aug 7, 2025 |